October 23, 2023
Researchers at Purdue University have developed a novel photosensitizer as a chemotherapeutic against triple negative breast cancer (TNBC). TNBC is the most prevalent form of cancer found in women and is considered the most aggressive form of breast cancer, comprising 15-20% of breast cancer cases. Current standard treatment for TNBC utilizes traditional chemotherapies. Unfortunately, traditional chemotherapies have high toxicity and often result in cancers with drug resistance. This has led to a dire need to discover novel treatments.
Purdue News: NOVEL CO-THERAPY FOR TRIPLE NEGATIVE BREAST CANCER
October 20, 2023
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
October 18, 2023
Encouraging physical activity is a well-established public health strategy that effectively supports disease prevention and health promotion across all age groups. In the US, Hispanic/Latino communities are part of a large minority population that experiences the burden of increased risk factors for cardiometabolic disease at disproportionate rates, and thus may benefit from strategies that support increased physical activity. In a recent publication supported by NHLBI, NIDDK, NCI, and others, researchers conducted a longitudinal study to assess correlates of physical activity patterns among adult participants of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) as well as among adult participants of the Framingham Heart Study (FHS), who are primarily white and non-Hispanic.
October 13, 2023
More young and middle-aged women are being diagnosed with lung cancer at a higher rate than men, and scientists are struggling to understand why, new research shows. Awareness of the disease’s effects on women is lacking, experts say, and the US government spends significantly less on its research than on similar studies in men.
Higher rates of lung cancer in women are a mystery for researchers
October 11, 2023
NIH is requesting information on the utility and useability of sample language and accompanying considerations developed for use in informed consent documents for digital health technologies utilized in research.
Request for Information: Developing Consent Language for Research Using Digital Health Technologies
September 20, 2023
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Researchers discover biomarker for tracking depression recovery
September 18, 2023
Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and 45, according to a new study by the National Institutes of Health. Researchers systematically reviewed published scientific studies that used AI/ML to analyze data to diagnose and classify PCOS and found that AI/ML based programs were able to successfully detect PCOS.
AI and machine learning can successfully diagnose polycystic ovary syndrome
September 18, 2023
A renowned scientist at Purdue University has received a $1.38 million grant to continue research involving a drug therapy used to fight drug-resistant strains of malaria in developing countries
Purdue News: Purdue researcher awarded $1.4M to further study malaria treatment
September 13, 2023
Joey Wallace’s work in the Bone Biology and Mechanics Lab at Purdue University in Indianapolis has focused on the role collagen in bone plays in several different disease models.
September 11, 2023
W. Andy Tao, professor of biochemistry at Purdue, led a team with Anton Iliuk of Purdue spinoff Tymora Analytical Operations to apply the company’s EVtrap technology to early testing for neurodegenerative diseases and cancer.
Purdue research: Liquid biopsy method may reveal signs of Parkinson’s disease in urine samples
